Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174598 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174601 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2024-05-09 | 2024-09-19 | 227471 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-05-09 | 2024-09-19 | 227474 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141107 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-06-26 | 2024-01-11 | 196406 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-09 | 190716 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2021-08-05 | 2021-12-02 | 143716 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2019-11-21 | 2020-01-30 | 99426 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2019-10-10 | 2019-11-28 | 96076 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2020-01-17 | 2020-04-02 | 103572 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-01-24 | 2020-04-09 | 104356 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2021-02-25 | 2021-03-04 | 134733 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-15 | 139734 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124980 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-10-30 | 2020-11-12 | 127610 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 128013 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2024-02-08 | 2024-03-28 | 218943 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2024-02-15 | 2024-03-28 | 219687 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Resolved | 2022-09-07 | 2023-07-28 | 168722 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |